Announced details
Drug discovery research on mRNA-targeting small-molecule and nucleic acid medicines, small-molecule screening targeting RNA, structure–activity relationship (SAR) analysis, and derivative design
Increase the efficiency of initial screening severalfold
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Small Science, a German scientific journal
| Item | Details |
|---|---|
| Names of Products / Services Covered | aibVIS, AISLAR（AI-augmented iterative screening of libraries against RNA targets） |
| Launch date | Scheduled for publication on 27 April 2026 (stated as the date on which the paper is to be published) |
| Applicable area | Drug discovery research on mRNA-targeting small-molecule and nucleic acid medicines, small-molecule screening targeting RNA, structure–activity relationship (SAR) analysis, and derivative design |
| Quantitative Effects | Increase the efficiency of initial screening severalfold |
| Source | Small Science, a German scientific journal |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To improve screening efficiency in drug discovery research on mRNA-targeting small-molecule and nucleic acid medicines, enabling the identification of RNA-binding compounds to which structure–activity relationship analysis can be applied and supporting rational derivative design.